Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase EARLY_PHASE1 × Enrolling by invitation × CNS × Clear all

Phase

Phase NA 5 Phase 1/2 4 Phase 1 4 Phase 2 2 Phase EARLY_PHASE1 1 Phase 4 1

Status

Completed 62 Recruiting 46 Terminated 25 Active not recruiting 23 Unknown 18 Not yet recruiting 17 Withdrawn 13 Enrolling by invitation 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 4 Thoracic 3 Genitourinary 3 Breast 2 Head & Neck 1 Gynecologic 1 Endocrine 1 CNS 1

Conditions

Glioblastoma IDH (Isocitrate Dehydrogenase) Wildtype 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07520214 2026-04-09

Clinical Study on the Safety and Immunogenicity of Specific Cancer Vaccines in Preventing Recurrence of Glioblastoma

Beijing Neurosurgical Institute

Phase EARLY_PHASE1 Enrolling by invitation

Glioblastoma IDH (Isocitrate Dehydrogenase) Wildtype

Data powered by HemOnc (CC BY 4.0) Colophon ⚡